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So, the question remains, which
of the available techniques for
expression pattern analysis most
accurately reflects biological reality?
The best answer may be ‘all of the
above’. No one technique
necessarily gives the whole picture.
Each can provide qualitatively
different types of information, and
all can help in the quest to
understand biological systems.
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The STAS domain — a
link between anion
transporters and
antisigma-factor
antagonists
L. Aravind*† and Eugene
V. Koonin†
Anion transporters of the sulfate
transporter family are of major
interest, as their malfunction is
implicated in three human diseases:
diastrophic dysplasia/achondro-
genesis type IB (DTD) [1,2],
Pendred’s syndrome (PDS) [3] and
congenital chloride diarrhoea (CLD)
[4]. The CLD gene is also
downregulated in intestinal
adenomas and adenocarcinomas [5].
The products of these genes are
distinct but related anion
transporters that contain 12 trans-
membrane helices followed by a
cytoplasmic domain at the carboxyl
terminus. The DTD gene encodes a
sulfate transporter [6], the PDS gene
a potential iodide-chloride
transporter [7] and the CLD gene a
chloride–NaHCO3– exchanger [8].
Related transporters with the same
domain organization, mainly
involved in sulfate transport, are
present in other eukaryotes and in
many bacteria [9]. 
We describe here an unexpected,
statistically significant similarity
between the carboxy-terminal
cytoplasmic domains of these
transporters and the bacterial
antisigma-factor antagonists (ASA)
typified by Bacillus subtilis SPOIIAA.
In a PSI-BLAST search [10,11]
seeded with the SPOIIAA sequence
from Bacillus stearothermophilus, with
a profile inclusion cut-off of 0.01, the
carboxy-terminal domain of the
human disease-associated
transporters and their eukaryotic and
bacterial homologs were detected
with random expectation (E) values
of 10–3–10–4 within five iterations. In
reciprocal searches initiated with the
CLD transporter carboxy-terminal
domain, bacterial ASAs were
detected with E values of 10–4–10–6
in the third iteration. 
The nuclear magnetic resonance
structure of the ASA SPOIIAA [12]
provides the structural framework for
the emerging domain superfamily. A
multiple alignment of this
superfamily was constructed using
the CLUSTALW program [13] and
adjusted using the PSI-BLAST
results (Figure 1). The alignment of
the carboxy-terminal domains of
anion transporters was used for
secondary structure prediction-based
threading through the Protein
Databank (PDB) database using the
PHD-TOPITS program [14]. The
best hit was the PDB entry for
SPOIIAA (PDB code 1AUZ), with a
Z-score of 3.1, which strongly
suggests a structure similar to that of
SPOIIAA. Thus, ASAs and the
cytoplasmic portions of anion
transporters define a previously
undetected, ancient, conserved
domain that we named STAS after
sulfate transporters and antisigma-
factor antagonists.
By mapping the conserved motifs
apparent from the multiple alignment
(Figure 1) onto the SPOIIAA
structure (Figure 2), the conservation
was traced largely to the four strands
that form the scaffold of the STAS
domain. In addition, the turn between
the two amino-terminal strands and
the long loop between strand 3 and
helix 2  are strongly conserved and
inserts appear not to be tolerated in
these elements (Figures 1,2).  Most of
the variability is in the loop between
helix 1 and strand 3, with α-helical
inserts of considerable size seen in
some of the anion transporters
(Figure 1). A comparison of the
alignment with the tertiary structure
shows that the carboxy-terminal
region of the STAS domain forms a
characteristic α-helical handle-like
structure (Figures 1,2).
The identification of the STAS
domain in the ASAs and the anion
transporters provides functional
clues for the regulation of anion
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transport. ASA-like proteins have
been found in a variety of bacteria,
such as Gram-positive bacteria,
Actinomycetes, Cyanobacteria,
chlamydiae, Treponema and
Thermotoga. These proteins
positively regulate sigma factors by
interacting with the anti-sigma
factor — a protein kinase. This
kinase, in turn, phosphorylates the
ASA on a serine in the conserved
loop (Figure 2) and thus inactivates
it; the ASA can be re-activated
through dephosphorylation by a
phosphatase [15]. Thus, the STAS
domain is at the center of
protein–protein interactions in the
sigma-factor regulation network. 
It has been shown that SPOIIAA
binds GTP and ATP and possesses a
weak NTPase activity that is
abolished by phosphorylation or by
mutation of the phosphorylatable
serine in the conserved loop
(Figure 1) [16]. The strong
conservation of this loop in the STAS
domains (Figure 1) suggests that this
domain could possess general NTP-
binding activity. The conserved loop
is probably involved in phosphate-
binding and the β-sheet scaffold
could accommodate the rest of the
NTP molecule. This mode of ligand
binding resembles lipid binding by
Sec14 domains, which have the same
structural fold as SPOIIAA but show
no detectable sequence similarity to
the STAS domain [17,18]. Notably,
one of the mutations in PDS has
been mapped to the predicted
phosphate-binding loop and probably
results in its disruption (Figures 1,2). 
The presence of a predicted
NTP-binding domain in the
cytoplasmic portions of anion
transporters indicates that anion
transport could be regulated by
intracellular concentrations of GTP
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Figure 1
Multiple alignment of a selected set of STAS
domains from antisigma-factor antagonists
and anion transporters. The proteins are
named according to their systematic gene
name followed by the species abbreviation
and the GenBank identifier number. DTDST
is the sulfate channel mutated in DTD and
DRAT is the down-regulated in adenoma
transporter that is mutated in CLD. The
residues affected by mutations in PDS and
DTD as mentioned in the text are highlighted
in red and the phosphorylatable serine in
SPOIIAA is highlighted in blue. The coloring
of conserved positions in the alignment is
according to the 90% consensus:
hydrophobic (h, YFWLIVMA) and aliphatic
(l, LIVMA) residues highlighted in yellow,
small residues (s, SAGTVPNHD) colored
green, tiny residues (u, GAS) shaded green
and polar residues (p, STQNEDRKH)
colored pink. The secondary structure
elements are derived from the structure of
SPOIIAA and are indicated above the
alignment; cylinders represent α-helices and
arrows represent β-sheets. The thick line
corresponds to the conserved loop and the
broken line indicates the variable loop; in the
latter, the sequences of the inserts are
replaced by the number of amino acid
residues (see also Figure 2). The numbers
before and after the alignment indicate the
positions of the first and last residue of the
STAS domain in each of the aligned
proteins. The carboxyl terminus of each
protein is indicated by an asterisk where
applicable. The domain organization of those
proteins that have domains fused to STAS is
indicated to the right of the alignment
following brackets delineating the respective
sets of proteins. All the remaining proteins
contain the STAS domain alone, similar to
the antisigma factor antagonists. X is an
uncharacterized domain seen only in Gram-
positive bacteria; the kinase domain fused to
the STAS domain in a mycobacterial protein
is specifically related to the antisigma factor-
like serine kinases with a histidine-kinase
fold; PP2C is a phosphatase domain. The
species abbreviations are: Bs, Bacillus
subtilis; Bst, Bacillus stearothermophilus;
Ct, Chlamydia trachomatis; Ec, Escherichia
coli; Hi, Haemophilus influenzae;
Tp, Treponema pallidum;
Mtu, Mycobacterium tuberculosis;
Ssp, Synechocystis species;
Ce, Caenorhabditis elegans; Hs, Homo
sapiens; At, Arabidopsis thaliana. A more
complete alignment of STAS domain
sequences is available from:
ftp://ncbi.nlm.nih.gov/pub/koonin/STAS.
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and/or ATP. The NTPs are likely to
elicit specific conformational changes
in the STAS domain through binding
and/or hydrolysis. The critical role of
the STAS domain in anion
transporters is supported by a
number of mutations in PDS and
DTD that map to this domain
[3,19,20]. Experimental testing of
these predictions, for which bacterial
transporters with the same domain
architecture could serve as a model,
should clarify the regulation of these
important transporters, which appears
to be more complex than previously
suspected. We detected ASA-like
STAS domain proteins in some
bacteria (for example Escherichia coli)
that lack the typical sigma regulatory
system and new  members in Gram-
positive bacteria that are fused to
another ligand-binding domain — the
PAS domain (Figure 1). These STAS
proteins could represent new
bacterial regulatory systems.
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Figure 2
Structural features of the STAS domain. The
ribbon diagram was constructed from the
minimized average NMR structure of
SPOIIAA (PDB code 1BUZ) using the
Molscript program [21]. The regions of low
sequence conservation are colored grey,
including the loop that accommodates large
inserts in the anion transporters. The
conserved loop that is implicated in
nucleotide binding is colored purple. The
distinctive α-helical handle — a structural
feature that is seen in most members of this
superfamily and shared with the Sec14
superfamily — is indicated in blue. 1, poorly
conserved distorted carboxy-terminal helix;
2, conserved loop; Loop, loop with variable
inserts; Handle, α-helical handle; N, amino
terminus; C, carboxyl terminus.
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